[Clinical study of the therapeutic effect of Mefoxine].
The therapeutic efficacy of cefoxitin was studied in 15 patients with pulmonary or urinary infections, after other unsuccessful antibiotic treatment. The drug determined a total regression of clinical picture within 10 days of therapy. Our results show that brief periods of treatment are sufficient in order to obtain recovery and to avoid selection of resistant germs. Patients treated with cefoxitin did not present any intolerance. The conclusion is drawn that "Mefoxin" is useful in patients affected by infections resistant to common antibiotics.
D000038:Abscess / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002081:Buttocks; D002440:Cefoxitin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011702:Pyelitis / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects
D002440:Cefoxitin
Osservazioni cliniche sull'azione terapeutica del Mefoxin.